Obesity Drug Approvals - A Hidden Winner In Supernus

Healthcare Sector and Stocks Analysis from Seeking Alpha

Thu, 19 Jul 2012

By Red Acre Investments : With the back to back approval of obesity drugs from Arena Pharmaceuticals ( ARNA ) and Vivus Pharmaceuticals ( VVUS ), there is a third, hidden winner. We're not talking about Orexigen Theraputics ( OREX ) - which is also working on an obesity drug. OREX has had a nice ...

Read the rest of this article on Healthcare Sector and Stocks Analysis from Seeking Alpha

Related Topics:

Content Partners

Site Directory Site Map Our Products

Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News

International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland

Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.